Skip to Content
Merck
HomeServicesMillipore® CTDMO ServicesADC & Bioconjugation CDMO Services

ADC & Bioconjugation CDMO Services

Handling and dissolution of HPAPI in glove box by operator

ADC & Bioconjugation Services for Targeted Therapies

Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment by delivering highly potent active pharmaceutical ingredients (HPAPIs) directly to targeted cells, enhancing therapeutic effectiveness while reducing toxicity to non-target cells. Today’s bioconjugates incorporate diverse payloads and innovative antibody formats, broadening their applications across various therapeutic areas and improving patient outcomes.

With over 15 years of contract development and manufacturing experience, we excel in conjugating drug linkers to monoclonal antibodies (mAbs) in facilities specialized for handling highly potent compounds.

Our comprehensive CDMO services for ADCs and bioconjugates include integrated linker-payload and conjugation capabilities. As a focused and flexible partner, we support you every step of the way, offering also fill/finish capabilities both internally and through strategic third-party partnerships.

To support your pathway from clinical to commercial, we have formed a 5-year strategic alliance with Simtra Biopharma Solutions for streamlined drug substance and drug product ADC manufacturing services.

Talk to an Expert


Our Track Record

#1

We were the first commercially approved ADC manufacturer in North America

100+

Different constructs developed

70+

INDs enabled

260+

GMP drug substance batches released since 2008

100%

Scalable single-use technology in our manufacturing template


PROCESS DEVELOPMENT

Our extensive expertise encompasses a wide range of conjugation and linker-payload chemistries, along with various antibody formats, to support the process development of both traditional and novel bioconjugates.

Conjugation Chemistry Expertise: We specialize in diverse conjugation methods, including stochastic and fully reductive cysteine conjugations, lysine conjugation, and advanced site-directed conjugation techniques such as engineered cysteines, enzyme-assisted conjugation, and the incorporation of non-natural amino acids.

Linkers and Payloads: Our capabilities include process development of constructs with various chemistries, like: cytotoxic payloads, immunotoxins, oligonucleotides, dyes, antibiotics, and chelators.

Proven Process Validation and PPQ Experience: We boast a strong track record, including a successful Pre-Approval Inspection (PAI) in 2020.

Chromatographic Purification Development: We have significant expertise in chromatographic purification techniques.

Innovative Process Technologies: We leverage single-use equipment (since 2017) and Process Analytical Technology (PAT) implementation to achieve advanced process control.

Learn more

ADC Express™ Services

Our extensive bioconjugation expertise shortens the path to the clinic through rapid production of development-grade ADC construct libraries with antibody and/or linkers and payloads of choice for preclinical lead candidate selection.

  • Mini-prep scale: 10–20 mg ADC construct ± column purification
  • Medium-prep scale: up to 100 mg ADC ± column purification
  • Certificate of testing with key quality attributes

Learn more


A Global FootPrint

A Global Footprint

We are a single organization with a global network to deliver contract development, manufacturing, and testing services across all stages of the molecule value chain.

Madison & Verona, Wisconsin (HPAPIs)
Madison & Verona, United States (HPAPIs)

Our API manufacturing site and SafeBridge® certified facility. This 70,000 sq-foot facility builds upon our decades of high potency expertise and makes us one of the largest single-digit nanogram OEL CTDMO providers in the world.

Rockville, MD
Rockville, United States

Biosafety testing and manufacturing services span the product cycle from early pre-clinical development to licensed production. 

Scientist at drawing board
St. Louis, United States (ADC & Bioconjugation)

Our ADC & Bioconjugation Center of Excellence offers ADC and Bioconjugation capabilities from pre-clinical development to commercial manufacturing. 


Related Technical Resources




Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?